NCT06924684Active, not recruitingPhase 2
High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI
Efficacy Of High-Dose Rosuvastatin Preloading Before Primary Percutaneous Coronary Intervention In Patients Suffering From St-Elevation Myocardial Infarction
Source: ClinicalTrials.gov · Last updated 11 Apr 2025
Brief summary (registry, in English)
To compare the efficacy of high dose rosuvastatin preloading vs placebo before primary PCI in terms of MACE at 30 days
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 66 (estimated)
- First submitted
- 30 Dec 2024
- Start date
- 2 Dec 2024
- Primary completion date
- 23 Jun 2025
- Lead sponsor
- Sheikh Zayed Federal Postgraduate Medical Institute
- Diseases
- Coronary artery disease
- NCT number
- NCT06924684
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 66
- From 2 Dec 2024 to the primary completion date, 23 Jun 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Hemodynamically unstable patients. History or clinical evidence of any co-morbidities. Taking any medications regularly even statins.
Who the study is looking for
- Age 18-75 years Patients undergoing primary angiography
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shaikh Zayed Hsopital Coordinator of this site? Confirm its status | Lahore | Pakistan | Unknown status |
| Punjab Institute of Cardiology Coordinator of this site? Confirm its status | Lahore | Pakistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.